Home›Search›Pharmaceutical Patent Analyst

Pharmaceutical Patent Analyst

Taylor and Francis Ltd. · United Kingdom · Est. 1993

ISSN2046-8954

SJR Q3✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.264

H-Indexi

SNIPi

0.304

Total Worksi

552

Total Citationsi

3,342

2yr Mean Citednessi

1.29

Open Impact Factor alternative

Aims & Scope

Subject areas: Medicine (miscellaneous); Pharmaceutical Science; Drug Discovery.

General Information

Country / RegionUnited Kingdom

Primary Language—

1st Year Published1993

Annual Volume~ 27 articles / year

StatusActive (last: 2024)

Total Publications552

Publisher OrgFuture Science Ltd

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2046-8954

✅

Indexed in a trusted database?

Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

311

2017

174

2018

101

2019

124

2020

100

2021

186

2022

2023

2024

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q3

Pharmaceutical ScienceQ3

Drug DiscoveryQ4

Subject Classification

Scopus Categories

Drug DiscoveryPharmaceutical ScienceMedicine (miscellaneous)

Research Topics (OpenAlex)

Intellectual Property and PatentsPharmaceutical Economics and PolicyBiomedical Ethics and RegulationHealth Systems, Economic Evaluations, Quality of LifeBiosimilars and Bioanalytical MethodsPharmaceutical studies and practicesCancer Research and TreatmentsBiotechnology and Related FieldsComputational Drug Discovery MethodsUbiquitin and proteasome pathways

Frequently asked questions about Pharmaceutical Patent Analyst

Is Pharmaceutical Patent Analyst a predatory journal?

PubScope has no integrity flags on record for Pharmaceutical Patent Analyst: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Pharmaceutical Patent Analyst?

Pharmaceutical Patent Analyst is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.264.

Is Pharmaceutical Patent Analyst indexed in Scopus and Web of Science?

Pharmaceutical Patent Analyst is indexed in Scopus.

What is the aims and scope of Pharmaceutical Patent Analyst?